期刊文献+

力达霉素效价单位及效价测定方法的确定 被引量:5

Definition of Potency Unit of Lidamycin and Establishment of the Potency Determination Method
在线阅读 下载PDF
导出
摘要 目的:确定力达霉素的效价单位,并建立力达霉素效价测定方法。方法:采用DNA断裂法确定力达霉素标准品引起DNA断裂的最低浓度,并据此浓度确定力达霉素标准品的效价;采用HPLC法分析力达霉素效价与其发色团峰面积的相关性,用力达霉素发色团的峰面积表征力达霉素的效价,用HPLC法测定力达霉素的效价。结果:将首批力达霉素标准品引起pBR322 DNA断裂成Ⅲ型的最低剂量规定为10-4力达霉素单位(u),即每1 mg首批力达霉素标准品的效价为896 u;力达霉素效价与其发色团峰面积呈线性关系(r=0.9995),根据力达霉素发色团的峰面积可以确定力达霉素的效价。结论:本文采用的效价单位确定方法"溯源性"明确;采用HPLC法测定力达霉素的效价可以大大提高传统生物检定的精度。 Objective:To define potency unit of lidamycin and establish the potency determination method. Methods : The potency of primary reference standard for lidamycin were defined in terms of the minimum valid concentration which could break DNA strands in DNA strand - scission test. The correlation between lidamycin potency and peak area of lidamycin chromophore were analyzed by HPLC. Thus,the potency of lidamycin could be represented by the peak area of chromophore and assayed by HPLC. Results:The minimum valid quantity of the primary reference substance for lidamycin which could break pBR322 DNA strands to form Ⅲ was defined as 10 -4 Lidamycin -unit (u) ,namely the potency of the primary reference substance for lidamycin is 896 units per milligram. The correlation between lidamycin potency and the peak area of lidamycin chromophore is linearity (r =0. 9995) . The potency of lidamycin could be assayed by peak area of the chromophore in HPLC. Conclusion: The traceability of the method used to define potency unit in this paper is definite and the accuracy of using HPLC to assay the potency of lidamycin is improved greatly than that of using traditional bioassay.
出处 《药物分析杂志》 CAS CSCD 北大核心 2004年第5期543-546,共4页 Chinese Journal of Pharmaceutical Analysis
关键词 力达霉素 效价测定 标准品 HPLC法 DNA断裂 低剂量 相关性 面积 单位 文采 lidamycin,reference standard,potency,HPLC
  • 相关文献

参考文献14

二级参考文献21

  • 1甄永苏,薛玉川,邵荣光.烯二炔类新抗生素C1027的抗肿瘤作用研究[J].中国抗生素杂志,1994,19(2):164-168. 被引量:31
  • 2Shao R G,药学学报,1995年,30卷,336页
  • 3Zhen Y S,J Antibiot,1989年,42卷,1294页
  • 4Hu J L,J Antibiot,1988年,41卷,11期,1575页
  • 5Xu Y J,Biochemistry,1997年,36卷,14975页
  • 6Zhen H Y,中华医学杂志,1997年,77卷,9期,657页
  • 7Zhen Y S,J Antibiot,1989年,42卷,8期,1294页
  • 8Otani T,Minami Y,Marunaka T,et al.A new macromolecular antitumor antibiotic,C 1027 Ⅱ .Isolation and physico chemical properties [J].J Antibiot Tokyo,1988,41(11): 1580- 1585.
  • 9Zhen YS,Ming XY,Yu B,et al.A new macromolecular antitumor antibiotic,C 1027 Ⅲ .Antitumor activity [J].J Antibiot Tokyo,1989,42(8): 1294- 1298.
  • 10Xu YJ,Zhen YS,Goldberg IH.C1027 chromophore,a potent new enediyne antitumor antibiotic,induces sequence specific double strand DNA cleavage [J].Biochemistry,1994,33( 19) : 5947- 5954.

共引文献44

同被引文献25

  • 1Otani T,Minami Y, Sakawa K,et al. Isolation and characterization of non - protein ehromophore and its degradation product from antibiotic C - 1027. J Antibiotics, 1991,44( 5 ) :564.
  • 2Otani T,Minami Y,Marunaka T. A new macromolecular antitumor antibiotic,C- 1027 11. Isolation and physico- chemical properties. J Antibiotics, 1988,41 ( 11 ) : 1580.
  • 3WHO. International Laboratory for Biological Standards,The proposed international standard for kanamycin. J Biol Stand, 1986,14:35.
  • 4Bangham D R,de Fonge H,van Noordwijk F. The cllaborative assay of the European pharmacopeia biological reference preparation for insulin. J Biol Stand, 1978,6:310.
  • 5Morag F, Dawn W, Bernard C. Report of collaborative study to establish the international standard for parvovirus B19 serum lgG. Biologicals, 1997,25:283.
  • 6WANG Zheng- fan(汪正范). Qualitative and quantitative chromatography (色谱定性与定量). Beijing (北京) : Chemical Industry Press (化学工业出版社), 2002.235.
  • 7TUGuo-Shi(涂国土).Preparation and establishment of China pharmaceutical reference materials (中国药品标准品的研制和建立)[J].中国药事,1996,10(1):50-50.
  • 8LEE MD, MANNING JK, WILLIAMS DR,et al. Calichemicins, a novel family of antitumor antibiotics 3 Isolation, purification and characterization of calichemicins β1^ Br, γ1^Br, α2^1, α3^1, β1^1, γ1^ 1 and δ1^1[J]. JAntibiot,1989,42(7):1070-1087.
  • 9THOMAS S,PREDA-PAIS A,CASARES S,et al. RNA degradation precedes DNA cleavage in autoreactive CD4 T cells suppressed by calicheamicin gammal [ J ]. lnt lmmunopharmacol, 2004,4(4) :521 -526.
  • 10DIJOSEPH JF,DOUGHER MM,ARMELLINO DC,et al. CD20- specific antibody-targeted chemotherapy of non-Hodgkin's B-cell lymphoma using calicheamicin-conjugated rituximab [ J ]. Cancer Immunol lmmunother,2007,56 ( 7 ) : 1107 - 1117.

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部